Efficacy of expanded periurethral cleansing in reducing catheter-associated urinary tract infection in comatose patients: a randomized controlled clinical trial
- PMID: 38741134
- PMCID: PMC11092077
- DOI: 10.1186/s13054-024-04947-7
Efficacy of expanded periurethral cleansing in reducing catheter-associated urinary tract infection in comatose patients: a randomized controlled clinical trial
Abstract
Background: The effect of the periurethral cleansing range on catheter-associated urinary tract infection (CAUTI) occurrence remains unknown. The purpose of this study was to evaluate the efficacy of expanded periurethral cleansing for reducing CAUTI in comatose patients.
Methods: In this randomized controlled trial, eligible patients in our hospital were enrolled and allocated randomly to the experimental group (expanded periurethral cleansing protocol; n = 225) or the control group (usual periurethral cleansing protocol; n = 221). The incidence of CAUTI on days 3, 7, and 10 after catheter insertion were compared, and the pathogen results and influencing factors were analyzed.
Results: The incidences of CAUTI in the experimental and control groups on days 3, 7, and 10 were (5/225, 2.22% vs. 7/221, 3.17%, P = 0.54), (12/225, 5.33% vs. 18/221, 8.14%, P = 0.24), and (23/225, 10.22% vs. 47/221, 21.27%, P = 0.001), respectively; Escherichia coli and Candida albicans were the most common species in the two groups. The incidences of bacterial CAUTI and fungal CAUTI in the two groups were 11/225, 4.89% vs. 24/221, 10.86%, P = 0.02) and (10/225, 4.44% vs. 14/221, 6.33%, P = 0.38), respectively. The incidences of polymicrobial CAUTI in the two groups were 2/225 (0.89%) and 9/221 (4.07%), respectively (P = 0.03). The percentages of CAUTI-positive females in the two groups were 9.85% (13/132) and 29.52% (31/105), respectively (P < 0.05). The proportion of CAUTI-positive patients with diabetes in the experimental and control groups was 17.72% (14/79), which was lower than the 40.85% (29/71) in the control group (P < 0.05).
Conclusion: Expanded periurethral cleansing could reduce the incidence of CAUTI, especially those caused by bacteria and multiple pathogens, in comatose patients with short-term catheterization (≤ 10 days). Female patients and patients with diabetes benefit more from the expanded periurethral cleansing protocol for reducing CAUTI.
Keywords: Catheter-associated urinary tract infection; Disinfection technology; Intensive care unit; Periurethral cleansing; Povidone-iodine.
© 2024. The Author(s).
Conflict of interest statement
The authors have no conflicts of interest to declare for the present study.
Figures




Similar articles
-
Povidone-Iodine, 0.05% Chlorhexidine Gluconate, or Water for Periurethral Cleaning Before Indwelling Urinary Catheterization in a Pediatric Intensive Care: A Randomized Controlled Trial.J Wound Ostomy Continence Nurs. 2017 Jan/Feb;44(1):84-88. doi: 10.1097/WON.0000000000000280. J Wound Ostomy Continence Nurs. 2017. PMID: 27824737 Clinical Trial.
-
Nursing interventions to reduce the risk of catheter-associated urinary tract infection: part 2: staff education, monitoring, and care techniques.J Wound Ostomy Continence Nurs. 2009 Mar-Apr;36(2):137-54. doi: 10.1097/01.WON.0000347655.56851.04. J Wound Ostomy Continence Nurs. 2009. PMID: 19287262 Review.
-
A comparison of the efficacy of normal saline and Savlon solutions in periurethral cleaning to reduce catheter-associated bacteriuria: A randomized control trial.Int J Infect Dis. 2021 Apr;105:702-708. doi: 10.1016/j.ijid.2021.02.086. Epub 2021 Feb 23. Int J Infect Dis. 2021. PMID: 33636356 Clinical Trial.
-
Efficacy and safety of preventing catheter-associated urinary tract infection by inhibiting catheter bacterial biofilm formation: a multicenter randomized controlled trial.Antimicrob Resist Infect Control. 2024 Sep 2;13(1):96. doi: 10.1186/s13756-024-01450-0. Antimicrob Resist Infect Control. 2024. PMID: 39218889 Free PMC article. Clinical Trial.
-
Effect of precision management scheme based on the best evidence summary on reducing catheter-associated urinary tract infection.Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023 Sept 28;48(9):1333-1342. doi: 10.11817/j.issn.1672-7347.2023.230173. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023. PMID: 38044644 Free PMC article. Review. Chinese, English.
Cited by
-
CAUTIon - not all UTIs are the same.Nat Rev Urol. 2025 Aug 1:10.1038/s41585-025-01065-z. doi: 10.1038/s41585-025-01065-z. Online ahead of print. Nat Rev Urol. 2025. PMID: 40751081 Free PMC article. Review.
References
-
- Flores-Gonzalez JC, Hernandez-Gonzalez A, Rodriguez-Lopez C, et al. Nosocomial urinary tract infection in critical pediatric patients. Med Intensiv. 2011;35(6):344–348. - PubMed
-
- Hu B, Tao L, Rosenthal VD, et al. Device-associated infection rates, device use, length of stay, andmortality in intensive care units of 4 Chinese hospitals: International Nosocomial Control Consortium findings. Am J Infect Control. 2013;41(4):301–306. doi: 10.1016/j.ajic.2012.03.037. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical